Growth Hormone Treatment Recruiting Phase 2 / 3 Trials for Somatotropin (DB00052)

IndicationStatusPhase
DBCOND0043256 (Growth Hormone Treatment)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05253287
Growth Hormone in Decompensated Liver CirrhosisTreatment